Compile Data Set for Download or QSAR
Report error Found 178 Enz. Inhib. hit(s) with all data for entry = 8551
TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258304BDBM258304(US9493485, 9-145)
Affinity DataIC50: 1.90nMpH: 4.5 T: 2°CAssay Description:Compounds are also assessed for BACE1 and Cathepsin D activity using an FP Assay. Compounds to be assessed (e.g. compounds as described in the above ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258329BDBM258329(US9493485, 13-182)
Affinity DataIC50: 2nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258287BDBM258287(US9493485, 9-128)
Affinity DataIC50: 4nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258309BDBM258309(US9493485, 9-150)
Affinity DataIC50: 4nMpH: 4.5 T: 2°CAssay Description:Compounds are also assessed for BACE1 and Cathepsin D activity using an FP Assay. Compounds to be assessed (e.g. compounds as described in the above ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258304BDBM258304(US9493485, 9-145)
Affinity DataIC50: 4.5nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258283BDBM258283(US9493485, 9-124)
Affinity DataIC50: 4.5nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258310BDBM258310(US9493485, 9-151)
Affinity DataIC50: 5nMpH: 4.5 T: 2°CAssay Description:Compounds are also assessed for BACE1 and Cathepsin D activity using an FP Assay. Compounds to be assessed (e.g. compounds as described in the above ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258290BDBM258290(US9493485, 9-131)
Affinity DataIC50: 5.70nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258289BDBM258289(US9493485, 9-130)
Affinity DataIC50: 6nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258301BDBM258301(US9493485, 9-142)
Affinity DataIC50: 6nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258291BDBM258291(US9493485, 9-132)
Affinity DataIC50: 6nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258307BDBM258307(US9493485, 9-148)
Affinity DataIC50: 6.80nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258295BDBM258295(US9493485, 9-136)
Affinity DataIC50: 7nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258277BDBM258277(US9493485, 8-113)
Affinity DataIC50: 7nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258313BDBM258313(US9493485, 9-154)
Affinity DataIC50: 7.5nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258303BDBM258303(US9493485, 9-144)
Affinity DataIC50: 8nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258306BDBM258306(US9493485, 9-147)
Affinity DataIC50: 8nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258288BDBM258288(US9493485, 9-129)
Affinity DataIC50: 8.30nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258282BDBM258282(US9493485, 9-123)
Affinity DataIC50: 8.70nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258298BDBM258298(US9493485, 9-139)
Affinity DataIC50: 9nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258280BDBM258280(US9493485, 9-121)
Affinity DataIC50: 9nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258292BDBM258292(US9493485, 9-133)
Affinity DataIC50: 9nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258309BDBM258309(US9493485, 9-150)
Affinity DataIC50: 9nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258310BDBM258310(US9493485, 9-151)
Affinity DataIC50: 9.70nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258305BDBM258305(US9493485, 9-146)
Affinity DataIC50: 9.80nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258294BDBM258294(US9493485, 9-135)
Affinity DataIC50: 10.5nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258285BDBM258285(US9493485, 9-126)
Affinity DataIC50: 11nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258297BDBM258297(US9493485, 9-138)
Affinity DataIC50: 11nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258281BDBM258281(US9493485, 9-122)
Affinity DataIC50: 12nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258320BDBM258320(US9493485, 9-161)
Affinity DataIC50: 13.5nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258321BDBM258321(US9493485, 9-162)
Affinity DataIC50: 15nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258317BDBM258317(US9493485, 9-158)
Affinity DataIC50: 15nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258292BDBM258292(US9493485, 9-133)
Affinity DataIC50: 16nMpH: 4.5 T: 2°CAssay Description:Compounds are also assessed for BACE1 and Cathepsin D activity using an FP Assay. Compounds to be assessed (e.g. compounds as described in the above ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258268BDBM258268(US9493485, 8-104)
Affinity DataIC50: 16nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258296BDBM258296(US9493485, 9-137)
Affinity DataIC50: 17nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258276BDBM258276(US9493485, 8-112)
Affinity DataIC50: 17nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258272BDBM258272(US9493485, 8-108)
Affinity DataIC50: 17.5nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258300BDBM258300(US9493485, 9-141)
Affinity DataIC50: 17.5nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258279BDBM258279(US9493485, 9-120)
Affinity DataIC50: 19nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258319BDBM258319(US9493485, 9-160)
Affinity DataIC50: 19.5nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258274BDBM258274(US9493485, 8-110)
Affinity DataIC50: 26nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258303BDBM258303(US9493485, 9-144)
Affinity DataIC50: 27nMpH: 4.5 T: 2°CAssay Description:Compounds are also assessed for BACE1 and Cathepsin D activity using an FP Assay. Compounds to be assessed (e.g. compounds as described in the above ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258323BDBM258323(US9493485, 9-164)
Affinity DataIC50: 27.5nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258301BDBM258301(US9493485, 9-142)
Affinity DataIC50: 28nMpH: 4.5 T: 2°CAssay Description:Compounds are also assessed for BACE1 and Cathepsin D activity using an FP Assay. Compounds to be assessed (e.g. compounds as described in the above ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258307BDBM258307(US9493485, 9-148)
Affinity DataIC50: 29nMpH: 4.5 T: 2°CAssay Description:Compounds are also assessed for BACE1 and Cathepsin D activity using an FP Assay. Compounds to be assessed (e.g. compounds as described in the above ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258306BDBM258306(US9493485, 9-147)
Affinity DataIC50: 29nMpH: 4.5 T: 2°CAssay Description:Compounds are also assessed for BACE1 and Cathepsin D activity using an FP Assay. Compounds to be assessed (e.g. compounds as described in the above ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258284BDBM258284(US9493485, 9-125)
Affinity DataIC50: 29nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258267BDBM258267(US9493485, 8-103)
Affinity DataIC50: 30nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258314BDBM258314(US9493485, 9-155)
Affinity DataIC50: 31nMpH: 7.0Assay Description:BACE1 activity can be assessed in an AlphaScreen assay. Compounds to be assessed (e.g. compounds as described in the above examples) are serially dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

TargetBeta-secretase 1(Human)
Imago Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 258329BDBM258329(US9493485, 13-182)
Affinity DataIC50: 32nMpH: 4.5 T: 2°CAssay Description:Compounds are also assessed for BACE1 and Cathepsin D activity using an FP Assay. Compounds to be assessed (e.g. compounds as described in the above ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2017
Entry Details
US Patent

Displayed 1 to 50 (of 178 total ) | Next | Last >>
Jump to: